Characterization of the breast cancer resistance protein (BCRP/ABCG2 ) in clear cell renal cell carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of the breast cancer resistance protein (BCRP/ABCG2
) in clear cell renal cell carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-07
DOI
10.1002/ijc.31741
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
- (2017) Axel Bex et al. EUROPEAN UROLOGY
- Metabolic reprogramming in clear cell renal cell carcinoma
- (2017) Hiromi I. Wettersten et al. Nature Reviews Nephrology
- Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors
- (2016) Claudia Neul et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
- (2016) Stefan Winter et al. Scientific Reports
- Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma
- (2015) Hongwei Liu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
- (2015) B. Beuselinck et al. CLINICAL CANCER RESEARCH
- CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma
- (2015) Meta H.M. Diekstra et al. EUROPEAN UROLOGY
- Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron
- (2015) Florian Büttner et al. EUROPEAN UROLOGY
- Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells
- (2015) LIXIA LV et al. Oncology Letters
- MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
- (2015) Pascale Fisel et al. Oncotarget
- Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance
- (2015) Eran E. Bram et al. NEOPLASIA
- MicroRNAs and their relevance to ABC transporters
- (2014) Sierk Haenisch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance
- (2014) Oliver Bruhn et al. Expert Opinion on Drug Metabolism & Toxicology
- Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
- (2013) Moritz C Oberstadt et al. BMC CANCER
- MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Xuyang Jiao et al. BREAST CANCER RESEARCH AND TREATMENT
- Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
- (2013) B Beuselinck et al. BRITISH JOURNAL OF CANCER
- DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome
- (2013) P. Fisel et al. CLINICAL CANCER RESEARCH
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Human Pregnane X Receptor Genotype of the Donor but Not of the Recipient Is a Risk Factor for Delayed Graft Function After Renal Transplantation
- (2012) I A Hauser et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- MicroRNA profiling in K-562 cells under imatinib treatment
- (2012) Eleonora Turrini et al. Pharmacogenetics and Genomics
- Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells
- (2011) Xin Li et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Role of ABCG2 and ABCB6 in Porphyrin Metabolism and Cell Survival
- (2011) Partha Krishnamurthy et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
- (2010) A. A. M. van der Veldt et al. CLINICAL CANCER RESEARCH
- Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)
- (2009) Wang Rui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
- (2009) K. K.W. To et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
- (2009) Y.-Z. Pan et al. MOLECULAR PHARMACOLOGY
- Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
- (2009) O. M. Woodward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
- The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration
- (2008) M. Huls et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane
- (2007) M. Huls et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More